Today: 2 June 2026
Browse Category

NASDAQ:JAY 2 June 2026

Bluejay Diagnostics Stock Nearly Triples After U.S. Manufacturing Deal — Here’s the FDA Catch

Bluejay Diagnostics Stock Nearly Triples After U.S. Manufacturing Deal — Here’s the FDA Catch

Bluejay Diagnostics shares soared 171% to $5.88 after announcing a U.S. manufacturing partnership for its Symphony sepsis-testing platform, as investors bet on the company’s move from clinical development to commercialization; however, the stock remains risky with ongoing capital needs, pending FDA clearance, and reliance on successful clinical and manufacturing milestones.
2 June 2026
·

Latest articles

Gaxos.ai Jumps 57% After Funding Disclosure From AWS

Gaxos.ai Jumps 57% After Funding Disclosure From AWS

2 June 2026
GXAI soared 57% to $1.87 on record volume after Gaxos announced Amazon Web Services is investing more in its AI sales-coaching platform, despite widening losses and high marketing costs; traders focused on AWS backing as a major validation, but the company gave no details on deal size, launch timing, or new revenue.
Shake Shack Stock Slides 10% After Guidance Cut: Why SHAK Is Under Pressure Now

Shake Shack Stock Slides 10% After Guidance Cut: Why SHAK Is Under Pressure Now

2 June 2026
Shake Shack shares plunged 10.3% to $55.82 after the company slashed its Q2 and 2026 sales and margin outlooks, citing macroeconomic uncertainty and competition, with revenue now seen at $415–$420 million and restaurant-level margins at 22–23%, both below prior forecasts, as investors react to clearer signs of weaker demand and high costs.
Nu Drops as BofA Calls Sell on Nubank CFO Change

Nu Drops as BofA Calls Sell on Nubank CFO Change

2 June 2026
Nu Holdings plunged 6.3% to $12.17 after BofA downgraded the stock to Underperform and slashed its price target to $10, citing uncertainty from CFO Guilherme Lago’s exit and rising credit risks in Brazil, even as the fintech grows abroad and reports surging revenue and customer numbers.
Go toTop